TCG Crossover Management, LLC
Annual return '25
+167.5%
SPY '25
+17.7%
Alpha
+149.8ptsvs SPY
Invested
$7B
Holdings
49
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ABVX
ABIVAX SA AMERICAN DEPOSITARY SHARES
Q1 2026: Exited (was 7.11M shares)
20.9%
02
$CGON
CG ONCOLOGY INC
Q1 2026: Exited (was 3.67M shares)
7.2%
03
$TNGX
TANGO THERAPEUTICS INC
Q1 2026: Exited (was 12.76M shares)
6.4%
04
$COGT
COGENT BIOSCIENCES INC
Q1 2026: Exited (was 5.87M shares)
5.5%
05
$CNTA
CENTESSA PHARMACEUTICALS PLC
Q1 2026: Exited (was 4.29M shares)
4.9%
06
$DNTH
DIANTHUS THERAPEUTICS INC
Q1 2026: Exited (was 1.68M shares)
4.1%
07
$TYRA
TYRA BIOSCIENCES INC
Q1 2026: Exited (was 2.90M shares)
3.6%
08
$IMVT
IMMUNOVANT INC
Q1 2026: Exited (was 1.66M shares)
3.2%
09
$BCRX
BIOCRYST PHARMACEUTICALS INC
Held since at least Q1 2024
3.0%
10
$MIRM
MIRUM PHARMACEUTICALS INC
Q1 2026: Exited (was 62.0k shares)
2.8%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:14 UTC.